LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
White House releases an update on the progress of the initiative to provide equitable access to COVID-19 testing and treatments in the US.
OIG report finds that $8 million of $40 million in claims made by such suppliers in a recent audit did not meet Medicare requirements.
NY federal court ruling sheds light on what constitutes “remuneration” banned by the Anti-Kickback Statute.
Partnership will make use of Illumina’s capabilities and expertise in large-scale genomic sequencing and quickly generate high-quality data.
Lawmakers blame pharmacy benefit managers for high drug prices, introducing a bill to prevent what they term unfair practices.
HHS pulls the plug on a Trump rule requiring regulations to expire automatically after 10 years.
In this week’s Labs in Court roundup, six physicians were accused of billing for unnecessary lab tests in connection with an earlier lab fraud complaint.
A systematic evidence-based review from the ACMG shows NIPS tests are an effective screening tool for general-risk pregnancies.
Lab employees who’ve worked from home may be less than willing to return to the facility, if the situation at Apple is anything to go by.
HHS will distribute OraSure’s InteliSwab COVID-19 rapid at-home antigen test kits to schools across the nation.